King Luther Capital Management Corp increased its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The firm owned 95,764 shares of the company’s stock after purchasing an additional 15,180 shares during the quarter. King Luther Capital Management Corp’s holdings in HealthEquity were worth $8,773,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Xponance Inc. lifted its stake in shares of HealthEquity by 0.8% in the 3rd quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after purchasing an additional 102 shares during the period. Truist Financial Corp lifted its stake in shares of HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after purchasing an additional 119 shares during the period. Fiduciary Trust Co lifted its stake in shares of HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after purchasing an additional 120 shares during the period. Larson Financial Group LLC increased its position in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after buying an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in HealthEquity by 9.5% during the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after buying an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. BTIG Research reduced their price objective on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. JPMorgan Chase & Co. reduced their price objective on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. UBS Group set a $110.00 price objective on HealthEquity in a research report on Tuesday, February 17th. Finally, Royal Bank Of Canada reduced their price objective on HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $111.79.
HealthEquity Stock Down 0.8%
HealthEquity stock opened at $86.56 on Thursday. The firm has a market cap of $7.26 billion, a price-to-earnings ratio of 35.19, a PEG ratio of 1.59 and a beta of 0.19. The stock has a fifty day simple moving average of $83.05 and a two-hundred day simple moving average of $86.78. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The company’s revenue was up 7.3% on a year-over-year basis. Equities analysts predict that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Further Reading
- Five stocks we like better than HealthEquity
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
